Weekly Digest: Feb 23 - Feb 27, 2026
A curated summary of the top protein engineering and structure prediction signals from Feb 23 - Feb 27, 2026.

Building something in Protein Design?
I love collaborating on new challenges. Let's build together.
Subscribe to Protein Design Digest
Daily curated signals from arXiv, PubMed, and BioRxiv.
🧬 Weekly Recap
Feb 23 - Feb 27, 2026
Missed a day? Here are the top research signals and tools from Monday to Friday, summarized in one place.
🏆 Top Signals of the Week
🗓️ Monday, Feb 23
Predicting the active sites of quinolone antibiotics interacting with organisms by deep learning and molecular docking.
🧬 Abstract
Quinolones (QNs) antibiotics have become one of the most commonly used antibacterial drugs for human and animals in the world. In this study, we focused on 19 common quinolone (QN) antibiotics and collected their bioassay activity data from the PubChem website. Subsequently, using deep learning techniques, we constructed 45 biological activity prediction models based on the PubChem BioAssay dataset. The prediction accuracy of all models exceeded 95%, with the exception of the model for CCRIS mutagenicity studies, which achieved an accuracy of 85.22 ± 0.17%. Collectively, these deep learning models can serve as reliable tools for the prediction and evaluation of quinolone antibiotics. The bioassay activity of 19 QNs antibiotics was predicted by developed models to fill in the missing activity data. It was found that QNs antibiotics were generally active against bacterial DNA repair enzymes and neurobehavioral related protein, including hypothetical protein HP1089, recBCD - exodeoxyribonuclease V subunit RecBCD, recombination protein RecB and SLC5A7. Molecular dynamics simulation results showed that all fluoroquinolone complexes with HP1089, recBCD, RecB, and SLC5A7 reached stable conformations after an initial 0-10 ns relaxation, Our research provides a theoretical basis and technical support for elucidating the regulatory mechanisms of organisms in response to environmental exogenous chemicals, the formulation of environmental protection and food safety policies, the risk assessment of novel compounds, and the development of eco-friendly pharmaceuticals.
🗓️ Tuesday, Feb 24
Self-Aware Object Detection via Degradation Manifolds
🧬 Abstract
Object detectors achieve strong performance under nominal imaging conditions but can fail silently when exposed to blur, noise, compression, adverse weather, or resolution changes. In safety-critical settings, it is therefore insufficient to produce predictions without assessing whether the input remains within the detector’s nominal operating regime. We refer to this capability as self-aware object detection. We introduce a degradation-aware self-awareness framework based on degradation manifolds, which explicitly structure a detector’s feature space according to image degradation rather than semantic content. Our method augments a standard detection backbone with a lightweight embedding head trained via multi-layer contrastive learning. Images sharing the same degradation composition are pulled together, while differing degradation configurations are pushed apart, yielding a geometrically organized representation that captures degradation type and severity without requiring degradation labels or explicit density modeling. To anchor the learned geometry, we estimate a pristine prototype from clean training embeddings, defining a nominal operating point in representation space. Self-awareness emerges as geometric deviation from this reference, providing an intrinsic, image-level signal of degradation-induced shift that is independent of detection confidence. Extensive experiments on synthetic corruption benchmarks, cross-dataset zero-shot transfer, and natural weather-induced distribution shifts demonstrate strong pristine-degraded separability, consistent behavior across multiple detector architectures, and robust generalization under semantic shift. These results suggest that degradation-aware representation geometry provides a practical and detector-agnostic foundation.
🗓️ Wednesday, Feb 25
ManCAR: Manifold-Constrained Latent Reasoning with Adaptive Test-Time Computation for Sequential Recommendation
🧬 Abstract
Sequential recommendation increasingly employs latent multi-step reasoning to enhance test-time computation. Despite empirical gains, existing approaches largely drive intermediate reasoning states via target-dominant objectives without imposing explicit feasibility constraints. This results in latent drift, where reasoning trajectories deviate into implausible regions. We argue that effective recommendation reasoning should instead be viewed as navigation on a collaborative manifold rather than free-form latent refinement. To this end, we propose ManCAR (Manifold-Constrained Adaptive Reasoning), a principled framework that grounds reasoning within the topology of a global interaction graph. ManCAR constructs a local intent prior from the collaborative neighborhood of a user’s recent actions, represented as a distribution over the item simplex. During training, the model progressively aligns its latent predictive distribution with this prior, forcing the reasoning trajectory to remain within the valid manifold. At test time, reasoning proceeds adaptively until the predictive distribution stabilizes, avoiding over-refinement. We provide a variational interpretation of ManCAR to theoretically validate its drift-prevention and adaptive test-time stopping mechanisms. Experiments on seven benchmarks demonstrate that ManCAR consistently outperforms state-of-the-art baselines, achieving up to a 46.88% relative improvement w.r.t. NDCG@10. Our code is available at https://github.com/FuCongResearchSquad/ManCAR.
🗓️ Thursday, Feb 26
A Neural Time-Series Learning Method for Accelerating Free-Energy Perturbation and Rare-Event Molecular Dynamics Simulations.
🧬 Abstract
Molecular dynamics (MD) simulations are central to materials and drug discovery yet remain computationally demanding, particularly for free-energy perturbation (FEP) protocols and rare-event sampling. Existing sequence-based accelerators, especially Long Short-Term Memory (LSTM) models, often fail to capture long-range temporal structure and provide sufficient expressive capacity in noisy trajectories. Here, we introduce BiLSTMK-MD, a neural time-series learning method that constructs a causality-preserving surrogate for MD and FEP trajectories to reduce sampling requirements. The approach couples a sliding-window bidirectional LSTM encoder, which preserves long-range correlations, with an attention mechanism to enhance temporally informative frames, while a Kolmogorov-Arnold network output layer applies expressive nonlinear readout to decode the attention-refined representation into the final output. A two-stage, fANOVA-guided Bayesian optimization process searches for the optimal hyperparameter configuration for each system. Across four data sets, BiLSTMK-MD achieves mean absolute errors below 1.5 kcal mol-1 for window-resolved free-energy increments, reconstructs dihedral free-energy basins from 1-10% of trajectories, and maintains performance across systems. In long-trajectory regimes, it affords up to 400-fold acceleration for FEP and >700-fold speedup for rare-conformation sampling over conventional MD/FEP simulation. This neural time-series surrogate therefore provides a route to reducing sampling demands for free-energy estimation and rare-event characterization.
🗓️ Friday, Feb 27
Discovery of potent ALK tyrosine kinase inhibitors for thyroid cancer via machine learning modeling, molecular docking, MD simulations, and DFT study.
🧬 Abstract
The ever-increasing need for effective therapeutic management of thyroid cancer (TC) necessitates the exploration of novel approaches for advanced drug discovery. The current study employed a robust computational pipeline integrating Machine Learning (ML) algorithms, QSAR modeling, molecular docking, molecular dynamics (MD), density functional theory (DFT), and network pharmacology to identify novel Anaplastic Lymphoma Kinase (ALK) tyrosine kinase inhibitors. An initial library of 3546 compounds from the CHEMBL4247 database was systematically filtered to 578. This screening utilized Lipinski’s rule of five, aided by QSAR and detailed PaDEL descriptor analysis. An ensemble ML model, specifically a Voting Classifier (VC) combining XGBoost, LightGBM, and ExtraTrees algorithms, attained high predictive accuracy (ROC-AUC = 0.99), facilitating a strong classification and prioritization of active leads. Molecular docking experiment identified five top hit ligands (60, 63, 124, 130, 204) having docking score ranging from -9.0 to -10.4 kcal/mol and also confirmed their strong binding affinities, which surpassed the native co-crystallized ligand used as a standard. Later on, ADMET studies were executed to explore their physicochemical properties. MD simulation trajectories and MM/PBSA analyses validated the notably conformational stability and favorable binding free energies of these hit complexes. Network pharmacology was incorporated to understand tentative mechanisms of action and potential off-targets, generating a protein-protein interaction (PPI) network. DFT-based frontier molecular orbital (FMO) analysis showed Ligand124 possessed the highest electrophilicity and optimal polarizability, consistent with its marked interaction stability in MD simulations. In addition, the molecular mechanisms of hit compounds against TC were elucidated using a network pharmacology approach, which revealed a compound-target network with crucial hub targets like AKT1 and TP53. Significant correlations with cancer-related pathways, such as PI3K-Akt and MAPK signaling, as well as key involvement in kinase activity, phosphorylation, and membrane signaling complexes, were observed by the enrichment analysis of the main targets. These comprehensive results imply that investigated hit compounds probably modulate the oncogenic signaling networks, especially those controlling cell survival, proliferation, and drug resistance, in order to achieve its anti-TC therapeutic actions. These findings highlight the fundamental ability of integrating ML and computational chemistry to accelerate therapeutic development for TC.
Why it matters: Enhances small-molecule or peptide docking accuracy for targeted drug discovery.
📚 All Papers & Quick Reads
🗓️ Monday, Feb 23
- A hardware demonstration of a universal programmable RRAM-based probabilistic computer for molecular docking.: Molecular docking is a critical computational strategy in drug discovery, but the diversity of biomolecular structures and flexible binding conformations create an enormous search space that challenges conventional computing. Quantum computing holds…
- Anti-malarial evaluation of some bioactive plant compounds: An integrated computational approach combining QSAR and molecular docking.: Malaria remains a major global health burden and motivates the search for new antiplasmodial chemotypes. Here, an integrated in-silico workflow was applied to assess four plant-derived compounds such as artemisinin (Artemisia annua L.), chamazulene…
- Predicting the active sites of quinolone antibiotics interacting with organisms by deep learning and molecular docking.: Quinolones (QNs) antibiotics have become one of the most commonly used antibacterial drugs for human and animals in the world. In this study, we focused on 19 common quinolone (QN) antibiotics and collected their bioassay activity data from the PubChem…
- Integrating machine learning and molecular simulations for the design of potent HDAC2 inhibitors in diffuse large B-cell lymphoma.: Histone deacetylase 2 (HDAC2) plays a critical role in the pathogenesis of diffuse large B-cell lymphoma (DLBCL), positioning it as an attractive therapeutic target. In this study, we applied an integrated computational strategy that combined machine…
- Synthesis, in vitro antimicrobial activity and docking studies of novel 1,2,4-oxadiazol based piperidin-1-yl-methanone analogues.: A set of novel 1,2,4-oxadiazol based piperidin-1-yl-methanone analogues (5a-k) was synthesized from 3-phenyl-5-(4-(piperidin-4-yl)phenyl)-1,2,4-oxadiazole (3) via a sequential hydrolysis, cyclization and the Schotten-Baumann reaction. The structures of…
- Comparative Binding Dynamics of Minibinder 8.6 and HBD3 With TLR3 as Adjuvants for Developing a Peptide-Based Multi-Epitope Subunit Vaccine Against mCRPC: A Molecular Dynamics Study.: Metastatic castration resistance prostate cancer (mCRPC) is the advanced state of prostate cancer where majority of patients succumb to ineffective treatment perspectives like androgen deprivation alongside salvage therapies. mCRPC is predominantly…
- Identifying the potential anti-lung cancer targets of Baicalein using a network pharmacology approach.: Background Lung cancer remains the deadliest malignancy globally. Although therapies, including immune checkpoint inhibitors and targeted therapy, have gradually prolonged overall survival, resistance and relapse still plague clinical management….
- Network Pharmacology-Based Analysis and In Vitro Experiments Validation Reveal Tormentic Acid Induces Apoptosis via PI3K/AKT/HSP90 Pathway in HepG2 Cells.: Tormentic acid (TA) has demonstrated potential anti-hepatocellular carcinoma (HCC) effects. This study aimed to explore the anti-HCC effect and underlying mechanisms of TA via network pharmacology, molecular docking, molecular dynamics simulation and in…
🗓️ Tuesday, Feb 24
- From sweetener to risk factor: Network toxicology, molecular docking and molecular dynamics reveal the mechanism of aspartame in promoting coronary heart disease.: Aspartame, a widely used non-nutritive sweetener, has been epidemiologically linked to coronary heart disease (CHD), although the underlying mechanisms remain unclear. This study employed an integrative computational strategy combining network toxicology,…
- Diethyl Phthalate (DEP) as a potential osteosarcoma risk factor: a multi-omics study integrating network Toxicology, single-cell RNA sequencing, and molecular docking.: Diethyl phthalate (DEP), a common plasticiser and endocrine disruptor, has been linked to cancer, but its role in osteosarcoma (OS) remains unclear. This study integrated network toxicology, transcriptomics, protein-protein interaction (PPI) analysis,…
- Transition Metal Complex Based On Phenoliccarboxylic Ligand: Spectroscopic Inspection, DFT/TDDFT Computations, Cytotoxicity and Molecular Docking Investigation.: The study was designed to explore the synthesis, characterization, and biological evaluation of a novel Mn-(II)-3-[(3-carboxy-2-hydroxyphenyl)-methyl]-2-hydroxybenzoic complex, [Mn-(CHB-2H)·4H2O)]·2H2O, in comparison to its corresponding ligand (CHB). The…
- Corrigendum to “Comparison on inhibitory effect and mechanism of inhibitors on sPPO and mPPO purified from ‘Lijiang snow’ peach by combining multispectroscopic analysis, molecular docking and molecular dynamics simulation” [Food Chem. 400 (2023) 134048].
- Deciphering the potential of flavonols as SARS-CoV-2 MPro inhibitors: an in silico investigation using pass prediction, molecular docking, molecular dynamics simulation and ADMET analysis.: In the fight against contagious diseases, COrona VIrus disease 2019 (COVID -19) has been a formidable oponent. The SARS-CoV-2 virus, the etiological agent of COVID-19 continues to pose global health risks due to the ongoing mutations and post-COVID…
- Self-Aware Object Detection via Degradation Manifolds: Object detectors achieve strong performance under nominal imaging conditions but can fail silently when exposed to blur, noise, compression, adverse weather, or resolution changes. In safety-critical settings, it is therefore insufficient to produce…
- Calibrated Adaptation: Bayesian Stiefel Manifold Priors for Reliable Parameter-Efficient Fine-Tuning: Parameter-efficient fine-tuning methods such as LoRA enable practical adaptation of large language models but provide no principled uncertainty estimates, leading to poorly calibrated predictions and unreliable behavior under domain shift. We introduce…
- Retraction: Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets.
🗓️ Wednesday, Feb 25
- Evaluation of plasticizer toxicity effects and mechanisms in gastric cancer based on network toxicology and molecular docking.: The hypothesized toxicity and potential molecular mechanism of gastric cancer induced by exposure of two plasticizers (DBP and DEP) were studied by network toxicology. Potential relevant targets were predicted through PharmMapper, SwissTargetPrediction,…
- Bio and Geno-toxic Activities of Cadmium- Arsenic Salts Combination And/or Fluoride in Female Rats Confirmed by Molecular Docking.: Heavy metals are increasingly recognized as major toxic agents and potential carcinogens. This research was designed to assess the biochemical and genetic toxicity that arises from the exposure to a combination of cadmium and arsenic salts and/or fluoride…
- Integrative network toxicology and molecular docking preliminarily explore the potential role of polystyrene microplastics in childhood obesity.: Childhood obesity is a severe global epidemic, and emerging evidence suggests environmental pollutants like polystyrene microplastics (PS-MPs) may disrupt metabolic homoeostasis though mechanistic insights remain limited. This study integrated…
- Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy.: Cancer remains a predominant cause of mortality worldwide, with conventional therapies often limited by adverse side effects and the development of drug resistance. Targeting receptor tyrosine kinases (RTKs), especially vascular endothelial growth factor…
- Rendezvous and Docking of Mobile Ground Robots for Efficient Transportation Systems: In-Motion physical coupling of multiple mobile ground robots has the potential to enable new applications like in-motion transfer that improves efficiency in handling and transferring goods, which tackles current challenges in logistics. A key challenge…
- Catechins in insomnia-Alzheimer’s disease comorbidity: A network pharmacology and molecular docking study.: The comorbidity of insomnia and Alzheimer’s disease (AD) is strongly driven by the interplay between circadian rhythm disruption and immune dysfunction. Catechins are multi-target polyphenols capable of modulating both processes, yet their precise…
- Folding Thermodynamics and Kinetics of the N-Terminal Domain of the Circadian Clock-Regulated Histidine Kinase SasA.: Despite groundbreaking advancements in protein structure prediction, particularly with AlphaFold2/3 and RoseTTAFold, the protein folding problem remains elusive. In this study, we investigate the folding kinetics of the N-terminal thioredoxin-like domain…
- ManCAR: Manifold-Constrained Latent Reasoning with Adaptive Test-Time Computation for Sequential Recommendation: Sequential recommendation increasingly employs latent multi-step reasoning to enhance test-time computation. Despite empirical gains, existing approaches largely drive intermediate reasoning states via target-dominant objectives without imposing explicit…
🗓️ Thursday, Feb 26
- Mechanistic exploration of bisphenol A in primary Sjögren’s syndrome using network toxicology, molecular docking, molecular dynamics simulations and experimental validation.: Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disorder marked by exocrine gland impairment and systemic manifestations. Environmental endocrine disruptors, including bisphenol A (BPA), have been associated with immunological dysregulation;…
- Mechanistic insights into triclosan-induced hepatotoxicity: A network toxicology and molecular docking approach.: Triclosan (TCS) is an artificially synthesized broad-spectrum antimicrobial agent, which is widely used in personal care products. It is a new endocrine disruptor and has potential health hazards to human body. Based on network toxicology and molecular…
- Development of new pyrazole-thiophene hybrids: synthesis, anticancer assessment, and molecular docking insights.: A novel series of pyrazole-thiophene hybrid derivatives (3a-c, 5a-c, 7a-c, and 9a,b) was synthesized through a one-step reaction pathway and structurally confirmed by various spectroscopic analyses. Hybridization of the pyrazole nucleus with the thiophene…
- Design, Synthesis, Anticancer Evaluation, and EGFR-Targeted Molecular Docking of Novel 4-(benzylidenehydrazone)-3-nitropyridine Derivatives.: A new series of 4-(benzylidenehydrazone)-3-nitropyridine derivatives (MVK8-1 to MVK8-14) was synthesized via condensation of 4-hydrazinyl-3-nitropyridine with substituted aromatic aldehydes using acetic acid as an efficient and green catalyst. The…
- Design and Synthesis of Novel Indazole-Sulfonamide Derivatives, Cytotoxicity, and Molecular Docking Insights.: A novel library of new indazole-sulfonamides were synthesized by as single step protocol and evaluated their invitro anticancer activity against three breast cancer cell lines viz. MCF-7, MDA-MB-231, and SKBR-3 cell employing Lapatinib as standard…
- Indene and indole-based compounds as potential antimicrobial agents: synthesis, activity, docking studies and ADME analysis.: The excessive use of antibiotics in recent years has led to an accelerated development of resistance in bacterial pathogens and thus to one of the greatest problems of our time: antibiotic resistance. Therefore, despite the large number of available drugs,…
- Bioactive Compounds From Coffea canephora Husks: Alpha Glucosidase Inhibition, Anti-Inflammatory Potential, Cytotoxicity, and In Silico Docking.: A novel terpenoid, coffeacanol B (1), and nine recognized chemicals (2-10) were found in Coffea canephora husks. DP4 probability analysis verified its absolute configuration. Compounds 1, 3, 4, 8, and 10 inhibited alpha-glucosidase with IC50 values ranging…
- A Neural Time-Series Learning Method for Accelerating Free-Energy Perturbation and Rare-Event Molecular Dynamics Simulations.: Molecular dynamics (MD) simulations are central to materials and drug discovery yet remain computationally demanding, particularly for free-energy perturbation (FEP) protocols and rare-event sampling. Existing sequence-based accelerators, especially Long…
🗓️ Friday, Feb 27
- Design, synthesis, and experimental evaluation of rupestonic acid derivatives as novel anti-tumor agents guided by network pharmacology and molecular docking.: This integrated study elucidates the antitumor potential of Artemisia rupestris L.’s primary bioactive component, rupestonic acid (RA), and advances a superior derivative through a systematic, multi-stage strategy. The investigation commenced with network…
- Network pharmacology, molecular docking, and in vivo experiments reveal the effects of Polygonati Rhizoma on periodontitis.: This study explores Polygonati Rhizoma’s therapeutic potential against periodontitis using network pharmacology, molecular docking, and experimental validation to uncover its mechanisms. Active ingredients and targets of Polygonati Rhizoma were sourced…
- SPD Learn: A Geometric Deep Learning Python Library for Neural Decoding Through Trivialization: Implementations of symmetric positive definite (SPD) matrix-based neural networks for neural decoding remain fragmented across research codebases and Python packages. Existing implementations often employ ad hoc handling of manifold constraints and…
- Disentangling coevolutionary constraints for modeling protein conformational heterogeneity.: Accurate characterization of multi-state protein conformations is crucial for understanding their functional mechanisms and advancing targeted therapies. Extracting coevolutionary constraints from homologous sequences helps reveal protein structure and…
- Bioactive oxadiazolo-benzodiazepines: synthesis, α amylase inhibition, antioxidant activity, molecular docking and DFT calculation.: This study aimed to design, synthesize, and biologically evaluate new oxadiazolo-benzodiazepine derivatives integrating two pharmacologically relevant scaffolds, and to investigate their antidiabetic and antioxidant potential supported by computational…
- Optimization-based Unfolding in High-Energy Physics: In High-Energy Physics, unfolding is the process of reconstructing true distributions of physical observables from detector-distorted measurements. Starting from its reformulation as a regularized quadratic optimization, we develop a framework to tackle…
- Query Matters: How Selection Strategies Influence Active Learning in Drug Discovery.: We present SimDMTA, an in silico framework designed to simulate the Design-Make-Test-Analyze (DMTA) cycle used in preclinical drug discovery. Using docking scores as a proxy for biological assays, the simulations allow factors controlling the efficiency of…
- Decoding Protein-Membrane Binding Interfaces from Surface-Fingerprint-Based Geometric Deep Learning and Molecular Dynamics Simulations.: Predicting protein-membrane interactions is a formidable challenge due to the subtle physicochemical features that distinguish membrane-binding regions of a protein surface as well as the scarcity of experimentally resolved membrane-bound protein…
🛠️ Tools & Datasets
- 🛠 Tool: GROMACS - High-performance molecular dynamics engine.
- 🛠 Tool: OpenMM - GPU-accelerated molecular simulation toolkit.
- 💾 Dataset: UniRef - Clustered protein sequence sets for fast similarity searches.
- 💾 Dataset: BFD - Big Fantastic Database for deep learning protein modeling.
- 🛠 Tool: AlphaFill - Ligand and cofactor transfer into AlphaFold models.
- 💾 Dataset: MGnify - Metagenomics resource for microbiome sequence data.
- 🛠 Tool: ReFOLD4 - Sophisticated protein structure refinement tool for improving model quality.
- 💾 Dataset: PDBbind - Binding affinity data with 3D structures of protein-ligand complexes.
- 🛠 Tool: FunFOLD5 - Automated system for protein ligand-binding site prediction and function annotation.
- 💾 Dataset: BioLiP - Verified biologically relevant ligand-protein interactions.
- 🛠 Tool: MultiFOLD/IntFOLD - High-performance protein structure prediction and quality assessment server.
- 💾 Dataset: SIFTS - Residue-level mapping between PDB, UniProt, and other resources.
🤖 AI in Research Recap
- DeepMind Spin-Off Unveils Proprietary ‘AlphaFold 4’-Scale AI, Sparking Excitement and Secrecy Concerns in Drug Discovery - ekhbary.com: DeepMind Spin-Off Unveils Proprietary ‘AlphaFold 4’-Scale AI, Sparking Excitement and Secrecy Concerns in Drug Discovery ekhbary.com
- Open source of the Congzi AI algorithm: Transforming ordinary artificial intelligence into physical experts - The Manila Times: Open source of the Congzi AI algorithm: Transforming ordinary artificial intelligence into physical experts The Manila Times
- The N-terminal region of Rad26 binds to RPA and promotes checkpoint signalling. - PLOS: The N-terminal region of Rad26 binds to RPA and promotes checkpoint signalling. PLOS
- Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times: Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences The Manila Times
- Deepmind CEO: AGI To Deliver 10X Industrial Revolution Impact In Just 1 Decade | AI Summit 2026 - Business Today: Deepmind CEO: AGI To Deliver 10X Industrial Revolution Impact In Just 1 Decade | AI Summit 2026 Business Today
- Tamarind Bio Secures $13.6M Series A to Make AI More Accessible for Biology - GEN - Genetic Engineering and Biotechnology News: Tamarind Bio Secures $13.6M Series A to Make AI More Accessible for Biology GEN - Genetic Engineering and Biotechnology News
- Sundar Pichai Reveals The Power Of AI, How It Helped Break Down Protein Structures | AlphaFold - Business Today: Sundar Pichai Reveals The Power Of AI, How It Helped Break Down Protein Structures | AlphaFold Business Today
- 5 minutes with Tania Dottorini - King’s College London: 5 minutes with Tania Dottorini King’s College London
- AI is transforming science – more researchers need access to these powerful tools for discovery - AOL.com: AI is transforming science – more researchers need access to these powerful tools for discovery AOL.com
- AI in the classroom, lab and field: How Google’s India push is opening new career pathways for students - MSN: AI in the classroom, lab and field: How Google’s India push is opening new career pathways for students MSN
- Doctoral Candidate Behrgen Smith Named Finalist for Hertz Foundation Fellowship - SBU News: Doctoral Candidate Behrgen Smith Named Finalist for Hertz Foundation Fellowship SBU News
🏢 Industry & Real-World Applications
- Fierce Pharma Asia—Gilead’s synthetic lethality deal; A Tokyo biotech IPO; Novo’s Ozempic China sales dip - Fierce Pharma: Fierce Pharma Asia—Gilead’s synthetic lethality deal; A Tokyo biotech IPO; Novo’s Ozempic China sales dip Fierce Pharma
- Biologics and other world-class therapies keep pro athletes and ‘weekend warriors’ at the top of their game - UCLA Health: Biologics and other world-class therapies keep pro athletes and ‘weekend warriors’ at the top of their game UCLA Health
- Experts react to FDA’s shift to single pivotal trials for most drugs - Regulatory Affairs Professionals Society | RAPS: Experts react to FDA’s shift to single pivotal trials for most drugs Regulatory Affairs Professionals Society | RAPS
- Novartis, UNP, Launch Up-to-$1.8B+ Macrocyclic Peptide Partnership - GEN - Genetic Engineering and Biotechnology News: Novartis, UNP, Launch Up-to-$1.8B+ Macrocyclic Peptide Partnership GEN - Genetic Engineering and Biotechnology News
- Novartis taps macrocycle biotech in $1.7B cardiovascular deal - FirstWord Pharma: Novartis taps macrocycle biotech in $1.7B cardiovascular deal FirstWord Pharma
- Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal - Fierce Biotech: Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal Fierce Biotech
- First Patients Dosed in Alphyn Biologics’ Phase 2 Trial of First-in-Class Topical Therapeutic for Molluscum Contagiosum - PR Newswire: First Patients Dosed in Alphyn Biologics’ Phase 2 Trial of First-in-Class Topical Therapeutic for Molluscum Contagiosum PR Newswire
- Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - PR Newswire: Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer PR Newswire
- Alumni-founded biotech firm enters partnership to advance treatment for undruggable targets - UC Santa Cruz - News: Alumni-founded biotech firm enters partnership to advance treatment for undruggable targets UC Santa Cruz - News
- FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases - HHS.gov: FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases HHS.gov
- China out-licensing wave rolls on with $1.2B Harbour, Solstice pact - FirstWord Pharma: China out-licensing wave rolls on with $1.2B Harbour, Solstice pact FirstWord Pharma
- UK Ag Biotech Startup Resurrect Bio Secures $8.1M in Successful Series A Round - Global AgInvesting: UK Ag Biotech Startup Resurrect Bio Secures $8.1M in Successful Series A Round Global AgInvesting
- Scientists Expand Biomedical Research Horizons with Breakthrough in Synthesizing Novel Amino Acids - Bioengineer.org: Scientists Expand Biomedical Research Horizons with Breakthrough in Synthesizing Novel Amino Acids Bioengineer.org
- Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026 - Stocktwits: Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026 Stocktwits
- Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN - Pharmaceutical Executive: Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN Pharmaceutical Executive
- IPO Tracker 2026: Generate’s IPO Could Reach $425M, Largest Raise Yet - BioSpace: IPO Tracker 2026: Generate’s IPO Could Reach $425M, Largest Raise Yet BioSpace
- Vir Biotech Soars On Global Collaboration With Astellas, Encouraging Prostate Cancer Drug Data - Nasdaq: Vir Biotech Soars On Global Collaboration With Astellas, Encouraging Prostate Cancer Drug Data Nasdaq
- Novo Nordisk and Vivtex partner to develop next-generation oral medicines for obesity and diabetes - The Manila Times: Novo Nordisk and Vivtex partner to develop next-generation oral medicines for obesity and diabetes The Manila Times
- Samsung Joins CEPI Vaccine Network to Prepare for Next Pandemic - GEN - Genetic Engineering and Biotechnology News: Samsung Joins CEPI Vaccine Network to Prepare for Next Pandemic GEN - Genetic Engineering and Biotechnology News
- This Philly-area vaccine maker wants to license data for AI learning - Technical.ly: This Philly-area vaccine maker wants to license data for AI learning Technical.ly
- AbCellera Biologics Inc. SEC 10-K Report - TradingView: AbCellera Biologics Inc. SEC 10-K Report TradingView
- Strengthening IPO Readiness for a Biotech Company - FTI Consulting: Strengthening IPO Readiness for a Biotech Company FTI Consulting
- Generate caps a strong month for biotech IPOs with $400M offering - BioPharma Dive: Generate caps a strong month for biotech IPOs with $400M offering BioPharma Dive
- DRUGS AND BIOLOGICS—D. Haw.: Preliminary injunction denied in AstraZeneca challenge to Hawai’i statute addressing 340B discounted drug delivery - VitalLaw.com: DRUGS AND BIOLOGICS—D. Haw.: Preliminary injunction denied in AstraZeneca challenge to Hawai’i statute addressing 340B discounted drug delivery VitalLaw.com
- Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics - The Manila Times: Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics The Manila Times
- Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration - GEN - Genetic Engineering and Biotechnology News: Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer Collaboration GEN - Genetic Engineering and Biotechnology News
💼 Jobs & Opportunities
- Postdoctoral Fellow - P Znamenskiy lab job with Francis Crick Institute | 12854646 - Nature (Nature Careers)
- Orthologue inference-based enzyme mining for diversification of the anti-cancer evodiamine scaffold - Nature (Nature Careers)
- Job Application for Intern, Clinical Operations at Eikon Therapeutics - Greenhouse (Greenhouse Boards)
- Job Application for Intern, Clinical Study Start-Up at Eikon Therapeutics - Greenhouse (Greenhouse Boards)
- Job Application for Staff Data Scientist, Graph ML at Valo Health - Greenhouse (Greenhouse)
- Job Application for Sr. Program Manager at Natera - Greenhouse (Greenhouse)
- Procter & Gamble hiring Post Doc - Bioinformatics Scientist in Mason, OH - LinkedIn (Bioinformatics Careers)
- Natera hiring Senior Bioinformatics Scientist (Oncology Product Development) in United States - LinkedIn (Bioinformatics Careers)
- Post-doctoral assistant department of Plant Biotechnology and Bioinformatics (29676) - Academic Positions (Academic Positions)
- Computational Biology jobs at International Baccalaureate® (IB) - Academic Positions (Academic Positions)
📅 Events
Enjoyed this digest? Subscribe above to get these dailies in your inbox every morning.